Wilmington Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$5.57M Buy
64,842
+4,478
+7% +$341K 0.09% 148
2014
Q1
$4.21M Buy
60,364
+20,934
+53% +$1.66M 0.07% 166
2013
Q4
$3.33M Sell
39,430
-64
-0.2% -$5.06K 0.06% 192
2013
Q3
$3.04M Sell
39,494
-1,010
-2% -$70.8K 0.05% 196
2013
Q2
$2.37M Buy
+40,504
New +$2.44M 0.05% 212

Other funds holding CELG

Wilmington Trust's CELG Position: Q2 2014 in Review

Wilmington Trust increased its Celgene Corp (CELG) stake by 7.4% in Q2 2014, buying an estimated $341K and bringing the position to 64,842 shares worth $5.57M. The position accounts for 0.09% of the portfolio, ranked #148.

Wilmington Trust first reported a position in CELG in Q2 2013 and has held it in 5 quarters since. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Wilmington Trust held 64,842 shares of Celgene Corp worth $5.57M as of Q2 2014.
  • Wilmington Trust bought 4,478 Celgene Corp shares in Q2 2014, an estimated $341K.
  • Celgene Corp made up 0.09% of Wilmington Trust's portfolio in Q2 2014, its #148 holding.
  • Wilmington Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 5 quarters since.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.